News

Bristol-Myers Squibb Company and Infinity Pharmaceuticals announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's Opdivo in combination with Infinity's IPI-549 in…
Read More...

Seattle Genetics announced that it has submitted a supplemental Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) based on data from the phase 3…
Read More...

Lonza and TRACON Pharmaceuticals announced the successful delivery of the first 2,000L single-use bioreactor (SUB) batch produced from the recently expanded Lonza Singapore site. The…
Read More...

MilliporeSigma launched its new BioContinuum Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and…
Read More...

Eli Lilly and Company and NextCure announced a multi-year collaboration focused on the discovery and development of immuno-oncology therapies. The collaboration seeks to discover novel…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LORBRENA® (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase…
Read More...

NuMedii announced the formation of a research collaboration with Johns Hopkins School of Medicine with the goal of discovering new targets and therapeutic options for pancreatitis. The…
Read More...

Denali Therapeutics Inc. announced that it will collaborate with Sanofi on the development of multiple RIPK1 inhibitor molecules with the potential to treat a range of neurological and…
Read More...

Pharmaceutical Product Development, LLC (PPD) has enhanced its global product development services, adding significant expertise in multiple therapeutic areas, including neuroscience,…
Read More...

PMI BioPharma Solutions, a specialty CDMO providing Contract Research, Drug Discovery, Development and Manufacturing Services officially formed in January of 2018, announced that David…
Read More...

Gilead Sciences and Tango Therapeutics announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted immuno-oncology treatments for…
Read More...

Novo Nordisk announced the expansion of its biopharm business with an agreement to acquire the US and Canadian rights to Macrilen(TM) (macimorelin), the first and only FDA-approved oral…
Read More...

AbbVie announced that the European Commission (EC) has approved the type-II variation application for VENCLYXTO (venetoclax) in combination with rituximab for the treatment of patients…
Read More...

Puration confirmed the developing joint venture agreement with Kali, Inc. and Nouveau Life Pharmaceuticals, Inc. to develop cannabis pharmaceutical products. Puration further confirms…
Read More...

As part of CoreRx, Inc's growth in expanding its cGMP manufacturing capabilities to support niche commercial products, we are pleased to announce the completed installation of the Optel…
Read More...

Avance Biosciences announced that its Houston facility was inspected by the U.S. Food and Drug Administration on October 01 through October 04, 2018.  This inspection focused on the…
Read More...

Genesis Biotechnology Group (GBG) and its CRO arm Genesis Drug Discovery & Development (GD3) announced today that it has entered into a partnership with Yale University to offer an…
Read More...

Distributed Bio announced a discovery collaboration with H3 Biomedicine, Inc. designed to help accelerate the discovery of novel cancer therapeutics. The collaboration will leverage…
Read More...

Novartis announced that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the…
Read More...

AstraZeneca has agreed to divest the prescription medicine rights to Nexium (esomeprazole) in Europe, as well as the global rights (excluding the US and Japan) to Vimovo …
Read More...